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 Social participation of adult patients with spinal muscular atrophy: frequencies, restrictions, 
satisfaction and correlating factors. 
 
Introduction We assessed social participation in 62 adults with spinal muscular atrophy 
(SMA) types 1c-4. 
Methods Outcome measure: Utrecht Scale of Evaluation Rehabilitation-Participation (USER-
P) with Frequency, Restrictions and Satisfaction scores. Hierarchical regression analysis.  
Results  Early (type 1,2,3a) and late onset (type 3b,4) SMA patients reported similar 
frequency and satisfaction scores. „Age‟, „motor skills‟, „pain‟ and „feelings of depression‟ 
correlated with frequency; „motor skills‟ and „feelings of depression‟ correlated with 
restrictions and „level of education‟, „fatigue‟ and „feelings of depression‟ correlated with 
satisfaction. Motor skills and feelings of depression explained 33% of variance in frequency 
of participation. Motor skills explained 26% of variance of restrictions in participation. 
Fatigue and feelings of depression explained 50% of  variance in satisfaction with 
participation.  
Discussion Motor skills, feelings of depression and fatigue are correlates of participation in 
daily life. This knowledge can be used to optimize care for SMA patients.  
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 INTRODUCTION 
Hereditary proximal spinal muscular atrophy (SMA) is an important genetic cause of 




The antisense oligonucleotide nusinersen  has been 
approved and has shown efficacy in altering the natural history of the disease.
2
 Other gene 
therapy trials are ongoing. However, there is currently no cure for SMA.
3,4,5    
 
The variety and severity of impairments and disabilities that accompany SMA have been 
described extensively.
6-10
 The consensus guidelines for supportive care outlines management 
for the most common medical complications (e.g. pulmonary problems, scoliosis) that occur 
primarily in childhood, but focus strongly on symptom management.
11
 Irrespective of SMA 
type, all patients will encounter moderate to severe disability in life.
 
There is, however, a 
striking lack of literature on how adult patients participate in daily life activities and how 
multidisciplinary care can optimize their participation. The few existing studies on 
participation among adult patients with a broad range of neuromuscular disorders have 
focused mainly on work, and the results of SMA patients were not reported separately.
12-15
 In 
another qualitative study, SMA patients rated their quality of life as „fine‟, but experienced 
the serious impact of progressive functional limitations on their daily activities.
16
 Patients 
emphasized their need to live a normal life and fully participate in social activities, including 
an active family role, work and maintaining optimism.
17 
Increasing our knowledge of 
participation among adult patients with SMA and factors associated with participation may 
help to optimize supportive care.  
Therefore, the first objective of this study was to describe the frequency of, and perceived 
restrictions in, participation and the related satisfaction levels of adult patients with SMA. The 
second objective was to determine whether selected subjective complaints (pain, fatigue, 
anxiety, feelings of depression) and coping style are associated with participation in adult 
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 correlates were selected based on studies showing associations between pain and fatigue, 
emotional distress, mood and coping strategies with participation and quality of life among 




Subjects and Procedures 
Adult patients with genetically confirmed SMA, regardless of type of SMA, aged 18 years or 
older at inclusion, were recruited for this study between September 2010 and December 2012. 
Patients were informed about the study and recruited through the Dutch patient organization 
for neuromuscular diseases (www.spierziekten.nl), through patient communities on the 
internet, through pediatricians, (pediatric) neurologists,  rehabilitation physicians and the four 
Dutch Centers for Chronic Respiratory Ventilation.  The only exclusion criterion was the 
inability to read Dutch. All patients were retrieved from the Dutch SMA database.
22 
For the 
purpose of this study, all patients were seen at the outpatient clinic of the Department of 
Neurology and Neurosurgery at the University Medical Center Utrecht for a structured 
interview and neurological examination. They were asked to complete questionnaires.  
This study was registered in the Dutch registry for clinical trials (study no. 
NL29692.041.09/29692). The Medical Ethics Committee of the University Medical Center 
Utrecht approved the research protocol. All patients gave informed consent prior to inclusion.  
 
Measures 
The SMA classification system was used to define SMA types 1-4 
6,23,24 
Participation was measured using the Utrecht Scale for Evaluation Rehabilitation-
Participation (USER-P), a self-report instrument with 32 items.
 
Validity and reproducibility of 
the USER-P scale are good.
25-29
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 Satisfaction scales, and each sum score is converted to a score on a scale ranging from 0 to 
100. Higher scores indicate more favourable levels of participation (higher frequency of 
activities, fewer restrictions, greater satisfaction). An example of a question for the Frequency 
scale is: “How many hours do you spend on household activities?”  
An example of a question for the Restrictions scale is: “Does your illness or condition 
currently limit your daily life concerning outdoor mobility?”. An example of a question for 
the Satisfaction scale is: “How satisfied are you with your current daily life concerning „going 
out‟ (eating out, visiting a cafe, the cinema, a concert, alone or with others).”  
 
Correlates 
We used a standardized questionnaire to document disease characteristics (age at diagnosis, 
age at loss of ambulation) and demographic characteristics (sex, age, relationship status, job 
status, level of education, whether living independently).   
To document motor skills we used the Expanded Hammersmith Functional Motor Scale 
(HFMSE), a validated test consisting of 33 items to assess motor skills of patients with 
SMA.
30,31 
 The maximum score is 66 points. Higher scores indicate better motor skills.  
To assess pain and fatigue we used the sub-domain scores „pain‟ (two items) and „vitality‟ 
(four items) of the Short Form 36-item Health Survey (SF-36).
32,33
 The vitality score is a valid 
instrument to measure fatigue, as shown by a high correlation between the SF-36 vitality 
score and scores on the Fatigue Symptom Inventory.
34
 Higher scores in the domain „pain‟ 
indicate that  patients experience less pain; higher scores in the domain ‟vitality‟ indicate that 
patients experience less fatigue and feel more vital.  
Feelings of depression and anxiety were assessed using the Hospital Anxiety and Depression 
Scale (HADS). 
35-37
 Seven items assess feelings of anxiety (HADS-A) and seven items assess 
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 D scales. A score of 8 or more on the HADS-A or HADS-D is an indication of anxiety or 
depressed mood.  
Coping strategies were assessed using the short version of the Coping Inventory for Stressful 
Situations (CISS-21).
38,39
 The CISS-21 has 21 items divided into three categories: problem-
targeted strategies (CISS-P), emotion-focused strategies (CISS-E) and avoidance strategies 
(CISS-A). Response options range from „not at all‟(1) to „very applicable‟(5). A higher score 
indicates a preference to use this particular coping strategy.  
 
Statistical analyses 
Descriptive statistics were used to describe characteristics of the study population and 
participation scores. Comparisons between all SMA types were not performed because of the 
small sample size. Since differences in quality of life were found between patients with a 
relatively early onset (i.e. SMA types 1-3a) and those with onset later in life (i.e. SMA types 
3b-4),
40
 we dichotomized the variable SMA types to early onset SMA (types 1-3a) versus late 
onset SMA (types 3-4) to compare outcomes between these two subgroups.   
In addition to the total scores on the USER-P, individual items of the Restrictions and 
Satisfaction subscales were dichotomized to quantify the presence of restrictions in and 
dissatisfaction with specific aspects of participation. The options “with difficulty”, “with 
assistance” and “not possible” on the restrictions subscale were defined as “restrictions”. The 
option “without difficulty” was defined as “no restrictions”. The answer options “satisfied” 
and “very satisfied” on the satisfaction subscale were defined as “satisfaction”. The answer 
options “very dissatisfied”, “dissatisfied” and “neutral” were defined as “dissatisfaction”. The 
answer option „not applicable‟ was defined as a missing variable.  
To detect differences in determinants of participation between early and late-onset SMA 
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 computed to determine relationships between potential determinants and participation of the 
total sample. Using Cohen‟s rule of thumb, a correlation of 0.10 was considered „small‟,  of 
0.30 „medium‟ and of 0.50 „large‟.41 
Determinants that showed a p-value < 0.1 in the bivariate correlation analysis were entered 
into a hierarchical linear regression model (Multi-step enter method). Variables were always 
entered in the same order: step 1: disease severity variables and demographics; step 2: 
subjective complaints. Residual analyses were performed and multi-collinearity was tested to 
search for violations of necessary assumptions in multiple regression.
42
 SPSS version 24 for 
Windows was used for analysis. 
 
RESULTS  
Sixty-two of 80 (78%) invited patients participated. Descriptive statistics are displayed in 
Table 1. We included four patients with SMA type 1c and onset before 6 months of age who 
never learned to sit independently but survived into adulthood. Median HADS-A and HADS-
D scores were low (Table 2). Patients with early onset SMA had significantly lower motor 
skills (HFMSE-scores) than those with late onset SMA. Significantly fewer patients with 
early onset SMA had a partner than patients with late onset SMA. Late onset patients reported 
more pain and more fatigue than early onset patients.  
Frequency (level) of participation:  Median participation scores are displayed in Table 3. 
There were no significant differences between patients with early and late onset SMA in the 
frequency of participation (Table 3). SMA patients spent most hours on unpaid work and 
household activities (Table 4). Only 39% of them had paid work and only 16% had a full-time 
job (36 hours a week or more). A detailed description of all participation activities performed 
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 Restrictions and satisfaction: Patients with early onset SMA experienced significantly more 
participation restrictions compared to patients with late onset SMA (Table 3). Table 5 shows 
that 16-97 % of patients felt restricted in daily activities. They felt most restricted in 
work/education, household chores, mobility outdoors (e.g. traveling by car, public transport or 
bike), going out (e.g. to a movie, pub, church, or shopping), physical exercise and visits to 
family and friends. There were no significant differences between patients with early and late 
onset SMA in satisfaction with participation (Table 3). Table 5 shows that 8-58 % of patients 
were dissatisfied about daily activities. They were most dissatisfied about performing 
household chores and physical exercise. 
Correlates of participation (Table 6). Bi-variable analysis showed a medium correlation 
between lower frequency of participation and older age, reduced motor skills and  pain. We 
found a medium correlation between  lower frequency of participation and more feelings of 
depression. Participation restrictions were largely correlated with reduced motor skills. There 
was a medium correlation between satisfaction with participation and level of education, ,  
fatigue and a large correlation with fewer feelings of depression.  
Table 6 summarizes results of the multivariable analysis. 33% of the variance in frequency of 
participation was explained by motor skills in combination with feelings of feelings of 
depression; 26% of the variance in restrictions in participation was explained by motor skills 
and 50 % of the variance in satisfaction with participation was explained by fatigue together 
with feelings of feelings of depression.  
 
DISCUSSION 
Patients with early onset SMA (type 1,2,3a) experienced more participation restrictions than 
patients with later onset SMA, but reported similar levels of frequency of participation and 










This article is protected by copyright. All rights reserved.
 restrictions in participation. In addition, subjective complaints, namely fatigue, pain and 
particularly feelings of  depression, were associated with participation scores in bivariate 
analyses. Coping styles were not associated with participation scores. In the multiple 
regression analyses, having feelings of depression proved to be the only subjective complaint 
independently related to participation (frequency and satisfaction).  
This study identifies the participation activities that pose most problems for adult patients 
with SMA. There are a few studies on specific domains of participation that enrolled patients 
with a broader range of neuromuscular diseases. Employment rates of 40-57 % were, for 
example, found in a mixed sample of patients with neuromuscular disorders.
12,13,14
 This 
percentage is not only similar to our findings, but also comparable to that of patients with 
spinal cord injury.
28
 Our data, therefore, seem to be in line with previous reports on 
participation in work activities of patients with moderate to severe motor impairments. 
Satisfaction scores of patients with SMA were also similar to those previously reported by 
patients with spinal cord injury and patients after stroke.
28,29
 It reflects the fact that patients in 
different situations are able to reorganize their social activities on average, in a satisfactory 
way, regardless of their restrictions and type of condition.  
Age at onset of SMA may also be relevant for satisfaction with participation, since patients 
with SMA type 1c-3a experienced more restrictions but similar levels of satisfaction as 
patients with a later onset. A possible explanation for this finding is that patients with early 
onset SMA might have adapted more successfully to living with severe physical limitations
 
from a very early age onwards.
43
 Patients with late onset SMA initially have normal motor 
development. Relevant physical limitations due to disease progression occur in adulthood. 
Continuous adaptation attempts might lead to enduring distress as these patients have to 
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 Although the incidence of feelings of depression among patients with SMA is not higher than 
in those with other neuromuscular diseases,
18,20,21
 the presence of feelings of  depression was 
inversely associated with both frequency of participation activities and satisfaction with 
participation. This suggests that it is important to monitor whether feelings of depression are 
present in adult patients with SMA, and if so, to consider psychological interventions in order 




Coping style was not associated with any aspect of participation. To the best of our 
knowledge, there are no studies on the relationship between coping style and social 
participation in patients with neuromuscular disorders. Studies have, however, been carried 
out on MS patients and spinal cord injury patients, and these also failed to find a relationship 
between coping styles and participation.
45,46 
The fact that healthy individuals exhibit higher 
levels of coping variability than patients with chronic disease may play a role in this.
47 
We 
cannot, however, exclude the possibility that coping styles are relevant for participation 
(satisfaction) in a subgroup of patients, in particular among patients with SMA type 3-4 who 
may face challenges of adaptation in later life.  
As in other studies,
 
pain was reported frequently, in particular by late onset patients.
18,48 
Causes of pain are multiple, and include spinal deformities, muscle cramps or neurogenic 
pain. Univariable analysis showed that pain is associated with the frequency of participation 
activities in patients with SMA, but when feelings of depression was entered into the model, 
pain did not add significantly to the model (see table 6).  
The limited sample size is an important limitation of this study. It allowed the (pre)selection 
of a limited number of possible correlates. We made this preselection based on the existing 
literature and clinical experience. In our study we included adult patients with SMA over the 
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 us the opportunity to assess the relevance of already known variables in a broader group of 
patients with SMA, thus expanding the clinical relevance of our study.  Follow-up studies 
should aim at a larger sample size to address the importance of other factors including 
endurance and stamina for motor activities, social support, upper extremity function and 
personal factors such as self-efficacy or illness perceptions, in particular since the largest 
portion of the variance in participation remains unexplained. Larger sample sizes would also 
allow more detailed subgroup analysis, for example, of subgroups with early and later onset. 
Although almost 80% of invited patients participated in this population-based study, we 
cannot fully exclude the possibility of inclusion bias, i.e., the selection of patients in a 
relatively good condition or of patients who experienced increasing problems (e.g. patients 
with SMA type 3b), which may have influenced the results of this study. 
In conclusion, this study showed that although less restricted, patients with late onset SMA do 
not feel greater satisfaction with their participation in daily life than patients with early onset 
SMA. Compared to other diagnoses (e.g. spinal cord injury), SMA patients appear to be as 
satisfied with their participation in daily activities. Late onset patients reported more fatigue 
and experienced more pain than patients with early onset SMA. Motor skills, fatigue and 
feelings of depression in particularly are correlates of participation in daily life. Although 
these findings do not fully explain variation in participation, addressing these problems may 
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 Abbreviations: 
SMA  spinal muscular atrophy 
SMN gene survival motor neuron 
USER-P Utrecht Scale of Evaluation Rehabilitation-Participation 
HFMSE  Expanded Hammersmith Functional Motor Scale 
SF-36  Short Form 36-item Health Survey 
HADS  Hospital Anxiety and depression Scale  
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Table 1. Demographics in the total population and in 2 subgroups, early versus late onset SMA 
 
 Total Type 1 Type 2 Type 3a Type 3b Type 4 Early onset Late onset 
N 62 4 21 13 20 4 38 24 
Sex, female  55% 75% 62% 62% 45% 60% 63% 50% 
Age in years
 
43.0 (20-70) 40.5 (24-51) 31.0 (20-68) 51.0 (20-66) 48.0 (20-70) 53.0 (43-69) 37.0 (20-68) 48.0 (20-70) 
Partner  61% 25% 38% 69% 80% 100% 47%* 83% 
Paid job 39% 25% 29% 31% 55% 50% 30% 54% 
Education         
- No /Secondary 
school 
66% 50% 72% 54% 65% 100% 64% 71% 
- Higher education 34% 50% 29% 46% 35% 0 37% 29% 
Living 
independent 
68% 75% 38% 85% 80% 100% 58% 83% 
Note: values are median (range). *Results differ significantly between groups (SMA types or early versus late onset) with p<0.05. NA, not 
applicable. Education, highest grade level completed; Partner: living separate or together = yes; Living independent: independent with/without 
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 Table 2. Disease severity and psychological factors in the total population and in 2 subgroups, early versus late onset SMA 
 
 Total Type 1 Type 2 Type 3a Type 3b Type 4 Early onset Late onset 
                          N 62 4 21 13 20 4 38 24 
Disease severity         
Motor skills 
(HFMSE) 
3.5 (0-66) 0 2.0 (0-20) 4.0 (0-35) 29.0 (0-66) 48.0 (43-53) 2.0*  (0-35) 32.5 (0-66) 
n=22 














Loss ambulation 18.5 (2-59) NA NA 17.6 (4-46) 35.1 (9-59) NA 13.9* (1-45) 34.5 (9-59 
Subjective 
complaints 
        










Vitality (SF-36) 62.5 (5-100) 70.0 (45-75) 70.0  
(30-100) 
80.0 (5-100) 55.0 (15-70) 57.5 (45-95) 75.0* (5-
100) 
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HADS-A 3.5 (0-21) 4.5 (3-9) 4.0 (0-10) 3.0 (0-9) 3.0 (0-21) 2.5 (2-3) 4.0 (0-10) 3.0 (0-21) 
HADS-D 2.0 (0-15) 2.0 (1-4) 1.0 (0-9) 2.0 (0-15) 3.5 (10-12) 2.0 (1-5) 1.5 (0-15)* 3.0 (1-12)  
Psychological 
factor 
        
CISS: 

















- Emotional 14.6 (7-32) 12.5 (8-15) 15.3 (7-25) 12.5 (7-19) 15.7 (7-32) 14.7 (11-18) 14.1 (7-25) 15.5 (7-32) 
- Avoidance  19.3 (7-31) 22.0 (16-27) 18.9 (12-28) 19.1 (7-31) 18.7 (9-27) 21.3 (11-28) 19.5 (7-31) 19.1 (9-28) 
Note: values are median (range). *Results differ significantly between groups (SMA types or early versus late onset) with p<0.05. NA, not 
applicable.  
Loss of ambulation: stop walking with aid, in years.  
Abbreviations: SMA, Spinal muscular Atrophy; HFMSE, Expanded Hammersmith Functional Motor Scale; MRC, Medical Research Council; 
SF-36, Short Form 36–item Health Survey; HADS, Hospital Anxiety and Depression Scale; HADS-A, Hospital Anxiety and Depression Scale; 
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Table 3. USER-P scores for the total population, and early versus late onset SMA 
 





Type 1  
n=4 
Type 2  
n=21 












34.5 (7-66) 32.1(21-43) 36.7 (17-49) 30.9 (7-50) 33.5 (18-48) 42.2 (23-66) 35.4 (7-50) 35.4 (18-66) 
- Frequency: 
work/education 
20.0 (0-45) 17.5 (10-40) 25.0 (0-40) 10.0 (0-30) 22.5 (0-45) 15.0 (5-35) 20.0 (0-40) 20.0 (0-45) 
-  Frequency:  
leisure 
activities 
48.6 (14-74) 42.9 (31-54) 54.3 (31-71) 48.6 (14-74) 44.3 (26-74) 55.7 (40-65) 50.0 (14-74) 47.1 (25-74) 
















Satisfaction 72.5  
(32-100) 
 71.9  
(47-86) 












Note: values are median (range).  
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SMA type, SMA types 1-4; Onset, early versus late onset SMA.  
Abbreviations: SMA, Spinal Muscular atrophy; USER-P, Utrecht Scale for Evaluation Rehabilitation-Participation. 
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 Table 4. USER-P, Frequency scale: hours per week (work/education) and times per month (leisure activities) spent per item, for the total 
population, N = 62 
 
Domains 
 Hours/week  
 Not at all 1-24 hrs ≥25 hrs 
Paid work  61% 18% 21% 
Unpaid work   44% 42% 15% 
Education   71% 18% 12% 
Household 34% 60% 7% 
  Times/month  
 Not at all 1-10 times >10 times 
Sports and physical exercise    44% 42% 15% 
Going out 10% 87% 2% 
Daytrips   11% 81% 8% 
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Visiting family or friends 3% 86% 11% 
Receiving visitors 3% 87% 10% 
Contact phone, computer 0 16% 84% 
Note: Education: only activities in the course of work, or in order to get work. 
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Table 5. Percentage of patients with perceived restrictions and dissatisfaction, for the total population, N=62 
 
 Restrictions  
Persisting problems 
% Dissatisfaction % 
Work/education 67 % (n=52) Work/education 15 % (n=39) 
Household chores 97 % (n=59) Household chores 43 % (n=56) 
Mobility outdoors 82% Mobility outdoors 31 % (n=61) 
Physical exercise 95 % (n=57) Physical exercise 58 % (n=50) 
Going out 71% Going out 31 % (n=61) 
Outdoor activities 79% Outdoor activities 31 %  (n=61) 
Leisure indoors 41 % (n=61) Leisure indoors 12 %  (n=61) 
Relationship partner 33 % (n=40) Partner relationship 7 % (n=39) 
Visits to family/friends 66%  Family relationships 10% 
Visits from family/friends 20 % (n=61) Friends and acquaintances 8% 
Telephone/computer contact 16 %   











This article is protected by copyright. All rights reserved.
  
Table 6. Bivariate and multivariable linear regression analyses for USER-P frequency, restrictions and satisfaction. Stepwise regression.  
 
 Frequency of participation Participation restrictions Satisfaction with participation 
 Bivariable Multivariable        Bivariable Multivariable               Bivariable Multivariable            
  Step 1    Step 2  Step 1 Step 2  Step 1  Step 2 
Characteristics ρ β β ρ β β ρ β β 
Sex, female 0.08  N.E. N.E. 0.05 N.E. N.E. -0.03 N.E. N.E. 
Age in years -0.28* -0.24 -0.05 -0.10 N.E. N.E. -0.01 N.E. N.E. 
Partner  0.03  N.E. N.E. 0.11 N.E. N.E. 0.06 N.E. N.E. 
Education, High 0.05  N.E. N.E. 0.06 N.E. N.E. 0.32* -0.37 -0.20 
Living  
independent 
-0.13  N.E. N.E. -0.01 N.E. N.E. -0.13 N.E. N.E. 
Motor skills  
(HFMSE)  
0.26* 0.27* 0.32* 0.59* 0.45* 0.47*  -0.04 N.E. N.E. 
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Note: ΔR2, change in R2 between two equations; R2, explained variance.  
*, all included variables significant correlation with outcome measure p<0.1.  
Abbreviations: USER-P, Utrecht Scale for Evaluation Rehabilitation-Participation; HFMSE, Expanded Hammersmith Functional Motor Scale; 
SF-36, Short Form 36–item Health Survey; HADS-A, Hospital Anxiety and Depression Scale; anxiety subscale; HADS-D, Hospital Anxiety and 
Depression Scale; depression subscale; CISS-21, Short Form of the Coping Inventory for Stressful Situations.  
Fatigue (SF-36) 0.19  N.E. N.E. -0.01 N.E. N.E. 0.42* N.E. 0.30* 
HADS-A 0.01  N.E. N.E. -0.05 N.E. N.E. -0.29 N.E. N.E. 
HADS-D -0.41* N.E. -0.44* -0.24* N.E. -0.23 -0.49* N.E. -0.41* 
CISS          
Task-oriented  -0.06  N.E. N.E. -0.14 N.E. N.E.  -0.03 N.E. N.E. 
Emotional 0.21  N.E. N.E. -0.11 N.E. N.E.  -0.00 N.E. N.E. 
Avoidance  -0.09  N.E. N.E. -0.05 N.E. N.E.   0.02 N.E. N.E. 
ΔR2  0.14* 0.19*  0.21* 0.05  0.14* 0.36* 
R
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